Acute viral infection results in a PD-1-dependent loss of anti-tumor CD8+ T cell responses: implications for tumor immunotherapy

Ítems similars

• PD-1 blockade reverses viral infection-induced loss of anti-tumor CD8+ T cell responses
  per: Huelsmann, Erica, et al.
  Publicat: (2013)
• Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
  per: Broucek, Joseph, et al.
  Publicat: (2014)
• Single-step nanoparticle antigen presentation system for tumor immunotherapy
  per: Kohlhapp, Frederick, et al.
  Publicat: (2015)
• Role of dose selection in successful interleukin-2 immunotherapy: solving the Goldilock’s Complex
  per: Zloza, Andrew, et al.
  Publicat: (2013)
• Combination immunotherapy with Interleukin-2 and CTLA-4 blockade decreases tumor growth and improves overall survival
  per: Broucek, Joseph R, et al.
  Publicat: (2013)